source
- Seawolf Therapeutics raises $100M and secures up to $1.2B partnership with Sanofi for DNA therapiesSeawolf Therapeutics announced it has closed a $100 million financing round. The capital came from a seed round led by Versant Ventures and a Series A round that included investors such as Eli Lill…
- Sofinnova Partners closes €725 million (≈$815 million) Crossover II fund to back ~15 European clinical-stage biotech firmsSofinnova Partners announced the closing of its largest fund to date, Crossover II, with €725 million (about $815 million) in capital. The fund plans to invest in roughly 15 clinical‑stage compani…Fierce Biotech · 3d agoDealPositive